In the image, the president of Brazil, Jair Bolsonaro (r), with his wife, Michelle. . / Cristóbal Herrera / Archive
(CRISTOBAL HERRERA /)
Sao Paulo, Aug 16 . .- The first lady of Brazil, Michelle Bolsonaro, announced this Sunday through her social networks that she is recovered from the new coronavirus, two weeks after having contracted the pathogen.
On her Instagram account, the wife of the Brazilian president, the far-right Jair Bolsonaro, shared a photo of the negative result of the test she underwent the day before to detect Sars-CoV-2, the cause of COVID-19, and He thanked the support he has received from his followers.
« Negative review. Thank you for the prayers and for all the expressions of affection, » wrote the first lady.
Michelle Bolsonaro, 38, was diagnosed with COVID-19 on July 30, a few days after the Brazilian president himself announced his recovery from the disease after being detained for twenty days.
This weekend, Bolsonaro’s youngest son, Renan Bolsonaro, also used social media to communicate that he tested positive for coronavirus.
The 22-year-old added that he began a treatment based on hydroxychloroquine, a drug strongly defended by the Brazilian president despite the fact that its effectiveness has not yet been scientifically proven.
In addition to Bolsonaro, his wife and their son, eight Brazilian government ministers have already been infected by COVID-19, as well as 12 of the country’s 27 regional governors.
Likewise, the grandmother of the first lady of Brazil died this week as a result of the disease, after spending more than a month admitted to a public hospital in Ceilandia, a city neighboring Brasilia.
Brazil, with 210 million inhabitants, is in absolute numbers the second country in the world hardest hit by the health emergency caused by the coronavirus, behind only the United States.
According to the most recent epidemiological bulletin of the Ministry of Health, released on Saturday, the country already accumulates more than 107,000 deaths and 3.31 million confirmed cases of COVID-19.